Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 14, No. 12, 2015, pp. 2179-2185
Bioline Code: pr15286
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 14, No. 12, 2015, pp. 2179-2185
© Copyright 2015 - Tropical Journal of Pharmaceutical Research
TGF-β1 and IL-10 expression in epithelial ovarian cancer cell line A2780|
Feng, Xin; Wang, Cia-Xia & Ou, Zhi-Ying
Purpose: Ovarian cancer is a leading cause of death among gynaecological malignancies.
Transforming growth factor-beta 1 (TGF-β1) and interleukin-10 (IL-10) are cytokines in the tumour
microenvironment and may play critical roles in immune suppression. This study highlights these roles
and immunosuppressive functions in epithelial ovarian cancer (EOC).
Methods: TGF-β1 and IL-10 expression was compared in malignant, benign, and borderline cancerous
tissues and tumour-free tissue by immunohistochemistry. Relationships among the levels of these
cytokines, correlation of expression level with EOC prognosis, and cytokine involvement in
immunosuppression were investigated.
Results: Immunohistochemical analysis of TGF-β1 and IL-10 in epithelial cells showed the presence of
epithelial, borderline, and benign ovarian tumour growth, and normal ovarian growth. TGF-β1 (P =
0.121), residual tumour after surgery (P = 0.231) and standard chemotherapy (P = 0.121) were
prognostic factors for EOC. There were no significant differences in clinicopathologic factors between
specimens expressing TGF-β1 at low and high levels, indicating that TGF-β1 is an independent factor in
EOC diagnosis. Higher concentrations of TGF-β1 (1754.690 ± 3416.487 pg/ml) and IL-10 (2731.7101 ±
6.1613 pg/ml) were observed in A2780-conditioned than in control medium.
Conclusion: TGF-β1 and IL-10 play pivotal roles in EOC and can lead to immune evasion. Targeting
these cytokines for tumour treatment, specifically at early stages, may prevent tumour progression.
Epithelial ovarian cancer; TGF-β1; IL-10; histopathology
Alternative site location: http://www.tjpr.org